PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Down 39.6% in August

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a large decline in short interest in August. As of August 14th, there was short interest totaling 265,900 shares, a decline of 39.6% from the July 30th total of 440,372 shares. Based on an average daily trading volume, of 216,457 shares, the short-interest ratio is currently 1.2 days. Approximately 32.8% of the shares of the company are sold short.

PMGC Price Performance

ELAB traded down $0.09 during trading on Monday, hitting $5.22. 8,051 shares of the company traded hands, compared to its average volume of 400,204. The company has a market cap of $4.23 million, a PE ratio of -0.00 and a beta of -0.25. The stock’s 50-day simple moving average is $9.77 and its two-hundred day simple moving average is $28.65. PMGC has a 1 year low of $5.06 and a 1 year high of $2,671.20. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 0.02.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research note on Friday, June 26th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.